There were 818 press releases posted in the last 24 hours and 438,367 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Vyome Therapeutics Begins Dosing in Phase 2 Trial of VB-1953 in Moderate to Severe Inflammatory Acne Vulgaris

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image